Business Medical Dialogues
    • facebook
    • twitter
    Login Register
    • facebook
    • twitter
    Login Register
    • Medical Dialogues
    • Speciality Dialogues
    • Education Dialogues
    • Medical Jobs
    • Medical Matrimony
    • MD Brand Connect
    Business Medical Dialogues
    • News
        • Financial Results
        • Hospitals & Diagnostics
        • IT / Health Venture
        • Implants / Devices
        • Insurance
        • Key Movement
        • Pharmaceuticals
        • Policy
        • Technology
        • pharma-news
    • blog
    LoginRegister
    Business Medical Dialogues
    LoginRegister
    • Home
    • News
      • Financial Results
      • Hospitals & Diagnostics
      • IT / Health Venture
      • Implants / Devices
      • Insurance
      • Key Movement
      • Pharmaceuticals
      • Policy
      • Technology
      • pharma-news
    • blog
    • Home
    • Editors Pick
    • NephroPlus to open up...

    NephroPlus to open up to 55 dialysis centres by 2018-end

    Written by supriya kashyap kashyap Published On 2017-10-31T09:35:34+05:30  |  Updated On 31 Oct 2017 9:35 AM IST
    NephroPlus to open up to 55 dialysis centres by 2018-end

    New Delhi: Dialysis service provider NephroPlus is looking to open up to 55 centres across India by the end of next year as part of its expansion plans, according to a top company official.


    The expansion in the Indian market could entail an investment of around Rs 55 crore.


    "We are planning to open around 50 to 55 centres by end of next year. We are aiming to increase our footprint across the length and breadth of the country," NephroPlus Founder and CEO Vikram Vuppalatold.


    The company currently has 126 dialysis centres in 81 cities in India, he added.


    When asked about locations of the new centres, Vuppala said the focus would be across different tiers of cities.


    The company had earlier said it would focus on tier II, III and tier IV cities such as non-metros, state capitals and large towns for expansion.


    When asked about investments, he said NephroPlus would be investing around Rs 1 crore per centre, which would have around 10-12 dialysis machines.


    On the funding of the expansion, Vuppala said: "We have already raised Rs 100 crore last September from the World Bank and BS capital hence we have adequate funds. We have also partnered with the HDFC bank and we have enough funds for next one and half year."


    When asked about overseas expansion plans, he said the company was also planning to have presence in five new countries in next five years without divulging details.

    dialysisHDFC bankIndian marketNephroPlusVikram Vuppalatoldworld bank
    Source : PTI

    Disclaimer: This site is primarily intended for healthcare professionals. Any content/information on this website does not replace the advice of medical and/or health professionals and should not be construed as medical/diagnostic advice/endorsement or prescription. Use of this site is subject to our terms of use, privacy policy, advertisement policy. © 2020 Minerva Medical Treatment Pvt Ltd

    supriya kashyap kashyap
    supriya kashyap kashyap
      Show Full Article
      Next Story
      Similar Posts
      NO DATA FOUND

      Popular Stories

      • Email: info@medicaldialogues.in
      • Phone: 011 - 4372 0751

      Website Last Updated On : 13 Oct 2022 5:14 AM GMT
      Company
      • About Us
      • Contact Us
      • Our Team
      • Reach our Editor
      • Feedback
      • Submit Article
      Ads & Legal
      • Advertise
      • Advertise Policy
      • Terms and Conditions
      • Privacy Policy
      • Editorial Policy
      • Comments Policy
      • Disclamier
      Medical Dialogues is health news portal designed to update medical and healthcare professionals but does not limit/block other interested parties from accessing our general health content. The health content on Medical Dialogues and its subdomains is created and/or edited by our expert team, that includes doctors, healthcare researchers and scientific writers, who review all medical information to keep them in line with the latest evidence-based medical information and accepted health guidelines by established medical organisations of the world.

      Any content/information on this website does not replace the advice of medical and/or health professionals and should not be construed as medical/diagnostic advice/endorsement or prescription.Use of this site is subject to our terms of use, privacy policy, advertisement policy. You can check out disclaimers here. © 2025 Minerva Medical Treatment Pvt Ltd

      © 2025 - Medical Dialogues. All Rights Reserved.
      Powered By: Hocalwire
      X
      We use cookies for analytics, advertising and to improve our site. You agree to our use of cookies by continuing to use our site. To know more, see our Cookie Policy and Cookie Settings.Ok